Cytomegaloviral control of MHC class I function in the mouse

Immunological Reviews

Volumn 168, Issue , 1999, Pages 167-176

  Hengel, Hartmut ^a   Reusch, Uwe ^a   Gutermann, Anja ^a   Ziegler, Heike ^a   Jonjic, Stipan ^b   Lucin, Pero ^b   Koszinowski, Ulrich H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; VIRUS PROTEIN;

COMPLEX FORMATION; CYTOMEGALOVIRUS; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS IMMUNITY;

ANIMALS; CARRIER PROTEINS; ENDOPLASMIC RETICULUM; GLYCOPROTEINS; GOLGI APPARATUS; HERPESVIRIDAE INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MUROMEGALOVIRUS; MUTATION; VIRAL PROTEINS;

EID: 0032998602     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01291.x     Document Type: Review

References (65)

1. 1. Mocarski ES. Cytomegaloviruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Virology. Vol 2. Philadelphia: Lippincott-Raven; 1996. p. 2447-2492.
2. 2. Chee MS, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990;54:125-169.
3. 3. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 1996;70:8833-8849.
4. 4. Reddehase MJ, Weiland F, Munch K, Jonjic S, Lüske A, Koszinowski UH. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985;55:264-273.
5. 5. Reddehase MJ, Mutter W, Münch K, Bühring HJ, Koszinowski UH. CD8 positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987;61:3102-3108.
6. 6. Shellam GR, Allan JE. Papadimirriou JM, Bancroft GJ. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA 1981;78:5104-5108.
7. 7. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-241.
8. 8. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994;179:1713-1717.
9. 9. Polic B, et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 1988;188:1047-1054.
10. 10. Kärre K. Express yourself or die: peptides, MHC molecules, and NK cells. Science 1995;267:978-979.
11. 11. Lanier LL. Natural killer cells: from no receptors to too many. Immunity 1997;6:371-378.
12. 12. Heemels MT, Ploegh HL. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995;64:463-491.
13. 13. Shepherd JC, et al. TAP 1-dependent peptide translocation in vitro is ATP dependent and peptide selectice. Cell 1993;74:577-584.
14. 14. Androlewicz MJ, Anderson KS, Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP dependent manner. Proc Natl Acad Sci USA 1993;90:9130-9134.
15. 15. Neefjes JJ, Momburg F, Hämmerling GH. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993;261:769-771.
16. 16. Van Endert R, Tampe R, Meyer TH, Tisch R, Bach JF, McDevitt HO. A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1994;1:491-500.
17. 17. Rajagopalan S, Brenner MB. Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the indoplasmic reticulum. J Exp Med 1994;180:407-412.
18. 18. Suh WK, Cohen-Doyle MF, Früh K, Wang K, Peterson PA Williams DB. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994;264:1322-1326.
19. 19. Ortmann B, Androlewicz M, Cresswell P. MHC class I / β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994;368:864-867.
20. 20. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996;5:103-114.
21. 21. Lindquist JA, Jensen ON, Mann M, Hämmerling GJ. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J 1998;17:2186-2195.
22. 22. Del Val M, Münch K, Reddehase MJ, Koszinowski UH. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 1989;58:305-315.
23. 23. Del Val M, et al. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 1992;172:729-738.
24. 24. Ziegler H, et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 1997;6:57-66.
25. 25. Burgert HG, Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 1985;41:987-997.
26. 26. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 1996;93:10990-10995.
27. 27. Jones TR, Wiertz EJHJ, Sun L, Fish KN, Nelson JA, Ploegh HL. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 1996;93:11327-11333.
28. 28. Jackson MR, Nilsson T, Peterson PA. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 1990;9:3153-3162.
29. 29. Thäle R, Szepan U, Hengel H, Geginat G, Lucin P, Koszinowski UH. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol 1995;69:6098-6105.
30. 30. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH. A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation. EMBO J 1998;18:1081-1091.
31. 31. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem 1995;270:1443-1448.
32. 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J Immunol 1996;157:4503-4510.
33. 33. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-850.
34. d molecules capture peptides from endocytosed hepatitis B surface antigens praticles for major histocompatibiltiy complex class I-restricted presentation. Eur J Immunol 1996;26:2812-2822.
35. 35. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990;63:707-716.
36. 36. Letourner F, Klausner RD. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 1992;69:1143-1157.
37. 37. Kleijnen M, et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 1997;16:685-694.
38. 38. Boes B, Hengel H, Ruppert T, Multhaupt G, Koszinowski UH, Kloetzel PM. Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 1994;179:901-909.
39. 39. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 1994;68:289-297.
40. 40. Geginat G, Ruppert T, Hengel H, Holtappels R, Koszinowski UH. Interferon-γ is a prerequisite for efficient antigen processing of viral peptides in vivo. J Immunol 1997;158:3303-3310.
41. 41. Heise M, Connick M, Virgin HW, Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 1998;187:1037-1046.
42. 42. Miller DM, et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998;187:675-683.
43. 43. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-6588.
44. 44. Sinzger C, Plachter B, Grefte A, The TH, Jahn G. Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 1996;173:240-245.
45. 45. Hengel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol 1998;6:190-1997.
46. 46. Hengel H, et al. A viral ER resident glycoprotein inactivates the MHC encoded peptide transporter. Immunity 1997;6:623-632.
47. 47. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US1 1 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996;84:769-779.
48. 48. Wiertz EJHJ, et al. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996;384:432-438.
49. 49. Ahn K, et al. The ER luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997;6:613-621.
50. 50. Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci USA 1997;94:6904-6909.
51. 51. Hengel H, Flohr T, Hämmerling GJ, Koszinowski UH, Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J Gen Virol 1996;77:2287-2296.
52. 52. Campbell AE, Slater JS, Cavanaugh VJ, Stenberg RM. An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T cells. J Virol 1992;66:3011-3017.
53. 53. Warren AP, Ducroq DH, Lehner PJ, Borysiewicz LK. Human-cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J Virol 1994;68:2822-2829.
54. 54. Hengel H, Eßlinger C, Pool J, Goulmy E, Koszinowski UH. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 1995;76:2987-2997.
55. + CTL recognize HSV-2 infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled. J Immunol 1996;156;3901-3910.
56. 56. Slater JS, Campbell AE. Down-regulation of MHC class I synthesis by murine cytomegalovirus occurs in immortalized but not primary fibroblasts. Virology 1997;229:221-227.
57. 57. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RS, Campbell AE. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 1995;69:4830-4841.
58. 58. Söderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-126.
59. 59. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US1 1. J Exp Med 1998;188:497-503.
60. 60. Moretta A, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA C molecules in human natural killer cells. J Exp Med 1995;182:875-884.
61. 61. Mandelboim O, et al. Multiple receptors for HLA G on human natural killer cells. Proc Natl Acad Sci USA 1997;94:14666-14670.
62. 62. Farrell HE, et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997;386:510-514.
63. 63. Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski UH. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 1997;94:14759-15763.
64. + cytolytic T cells. Nature 1990;344:742-746.
65. 65. Jonjic S, Del Val M, Keil GM, Reddehase MJ, Koszinowski UH. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J Virol 1988;62:1653-1658.